What is Keytruda and how does it work? Experts explain the cancer immunotherapy as a global investigation raises concerns ...

Keytruda is approved by the Drug Controller General of India (DCGI) for multiple cancer types. As of recent approvals, it ...

A game changer in cancer treatment, Keytruda, works by harnessing the body’s immune system to attack cancer cells. While its ...

Merck & Co.'s Keytruda in the U.S. starts at $12,000 for a 200 mg dose. Costs go up from there based on the insurer, provider ...

The Drug Controller General of India (DCGI) has approved Keytruda for multiple cancer types. As of recent approvals, it ...

(Reuters) -Gilead Sciences' Trodelvy in combination with Merck's blockbuster immunotherapy Keytruda lowered the risk of an aggressive type of breast cancer worsening by 35% when used as an initial ...

In India, Keytruda is approved by the Drug Controller General of India (DCGI) for multiple cancer types. As of recent ...

What is the Cancer Calculus investigation? The Cancer Calculus is a yearlong investigation by the International Consortium of ...

Keytruda, an immunotherapy drug, is transforming cancer treatment in India by helping the immune system fight cancer cells.

Merck built a wall of patents that keeps a cancer drug's price – and its profits – high. Hospitals often add to the cost for ...

Despite the president’s plan to lower prescription medicine costs, the price of many of the most expensive drugs — including ...